Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Electrocardiography wikipedia , lookup
Heart failure wikipedia , lookup
Mitral insufficiency wikipedia , lookup
Antihypertensive drug wikipedia , lookup
Cardiac surgery wikipedia , lookup
Quantium Medical Cardiac Output wikipedia , lookup
Jatene procedure wikipedia , lookup
Management of acute coronary syndrome wikipedia , lookup
Coronary artery disease wikipedia , lookup
Dextro-Transposition of the great arteries wikipedia , lookup
Arrhythmogenic right ventricular dysplasia wikipedia , lookup
Ejection fraction Definition Ejection fraction is an evaluation of the function of the left ventricle, also called left ventricular ejection fraction (LVEF). It calculates the proportion of blood ejected from the left ventricle with each heartbeat. If the percentage is lower than 50 percent, then cardiomyopathy may be present (Richard N. Fogoros, 2003). Role of molecular imaging The multiple gated acquisition (MUGA) scan is a non-invasive tool for assessing the function of the heart. The MUGA scan generates a non-static or moving image of the beating heart, which gives an accurate and reproducible means of measuring and monitoring the ejection fraction of the cardiac ventricles. In heart attack cases, a MUGA scan localizes the damaged portion of the heart muscle to evaluate extent of damage. Radiopharmaceutical Manufacturer Trade names Approved indications in adults Technetium-99m red blood cells Covidien UltraTag™ Tc99m-labeled red blood cells are used for: blood pool imaging including cardiac first pass and gated equilibrium imaging Technetium-99m sestamibi Cardinal Health Covidien DRAXIMAGE Lantheus Medical Imaging Pharmalucence Technetium-99m tetrofosmin GE Healthcare ® Myocardial perfusion agent that is indicated for: Detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (nonreversible defects) Evaluating myocardial function Developing information for use in patient management decisions Myoview™ Myocardial perfusion agent that is indicated for: Detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (nonreversible defects) The assessment of left ventricular function (left ventricular ejection fraction and wall motion) Cardiolite MSDS and package insert information © 2015 Cardinal Health. All rights reserved. CARDINAL HEALTH, the Cardinal Health LOGO and ESSENTIAL TO CARE are trademarks or registered trademarks of Cardinal Health. All other marks are the property of their respective owners. .